Watchlist Price Alert

Cidara Therapeutics Inc. (CDTX)

NASDAQ: CDTX · Real-Time Price · USD

21.48

-0.93 (-4.15%)

At close: Jun 17, 2025, 2:22 PM

Cidara Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	189.82M	35.78M	32.73M	62.27M	35.91M	60.27M	74.56M	75.31M	104.62M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	14.5M	19.25M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	96K	1.05M	634K	533K	2.02M	1.1M	1.27M	321K	190K
Receivables	1.69M	16.25M	5.83M	5.36M	11.18M	10K	n/a	321K	n/a
Inventory	n/a	6.1M	n/a	-2.59M	n/a	-5.55M	n/a	-321K	n/a
Other Current Assets	19.22M	2.73M	6.53M	2.59M	7.04M	10M	2.57M	n/a	779K
Total Current Assets	210.74M	60.85M	45.09M	71.7M	57.19M	65.81M	77.13M	77.67M	105.4M
Property-Plant & Equipment	3.96M	5.13M	1.43M	2.54M	1.21M	2.06M	712K	1.04M	1.37M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.06M	6.17M	2.5M	3.63M	3.23M	3.16M	1.98M	1.36M	1.56M
Total Assets	214.8M	67.03M	47.59M	75.33M	60.42M	68.98M	79.11M	79.03M	106.96M
Account Payables	3.61M	3.77M	1.45M	1.3M	4.57M	1.89M	2.85M	2.59M	2.91M
Deferred Revenue	n/a	25.09M	14.61M	13.92M	13.87M	9.8M	6.71M	n/a	n/a
Short-Term Debt	1.64M	n/a	n/a	3.74M	7.96M	10.78M	9.93M	2.67M	n/a
Other Current Liabilities	44.3M	32.22M	19.21M	9.05M	7.02M	3.25M	4.29M	n/a	n/a
Total Current Liabilities	49.55M	67.42M	29.97M	34.02M	38.56M	30.2M	19.89M	12.09M	8.91M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.21M	9.79M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	81K	n/a	80K
Total Long-Term Liabilities	1.93M	7.82M	20.52M	19.73M	11.14M	942K	81K	7.21M	9.87M
Total Liabilities	51.49M	75.24M	50.5M	53.75M	49.71M	31.14M	19.97M	19.29M	18.78M
Total Debt	3.58M	4.88M	1.32M	5.06M	7.96M	11.72M	9.93M	9.87M	9.79M
Common Stock	1K	9K	7K	7K	4K	3K	3K	2K	2K
Retained Earnings	-611.26M	-441.43M	-406.97M	-377.17M	-334.7M	-259.83M	-218.74M	-149.39M	-93.66M
Comprehensive Income	n/a	n/a	n/a	-0.00	n/a	n/a	0.00	-8K	-1K
Shareholders Equity	163.31M	-8.21M	-2.9M	21.57M	10.71M	37.84M	59.14M	59.74M	88.18M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	14.5M	19.25M